Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Sokol

Showing results (201-210 of 267) with videos related to

Pageof 27
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 3, 2023
Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trialMarc Hilmi, Maud Kamal, Sophie Vacher, et al.
Gut|October 2, 2020
Microbiota tryptophan metabolism induces aryl hydrocarbon receptor activation and improves alcohol-induced liver injuryLaura Wrzosek, Dragos Ciocan, Cindy Hugot, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2008
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patientsHarry Sokol, Bénédicte Pigneur, Laurie Watterlot, et al.
Ebiomedicine|January 29, 2023
A high-throughput sequencing approach identifies immunotherapeutic targets for bacterial meningitis in neonatesStéphanie Pons, Eric Frapy, Youssouf Sereme, et al.
Annals of the Rheumatic Diseases|December 5, 2023
Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritisDavid Moulin, Marie Millard, Mahdia Taïeb, et al.
NPJ Biofilms and Microbiomes|June 12, 2025
Gut microbiota alterations are linked to COVID-19 severity in North African and European populationsMarius Bredon, Pierre Hausfater, Loubna Khalki, et al.
Gut Microbes|January 29, 2022
AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptomsMaëva Meynier, Elodie Baudu, Nathalie Rolhion, et al.
Journal of Crohn'S & Colitis|February 26, 2022
Impact of the Ileal Microbiota on Surgical Site Infections in Crohn's Disease: A Nationwide Prospective CohortClément Julien, Emré Anakok, Xavier Treton, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 1, 2023
Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexiaAdeline Dolly, Sarah A Pötgens, Morgane M Thibaut, et al.
Bulletin Du Cancer|February 15, 2020
[Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment]Romain Cohen, Thomas Pudlarz, Marie-Line Garcia-Larnicol, et al.
Pageof 27

Showing results (201-210 of 267) with videos related to

Sort By:
Pageof 27
European Journal of Cancer (Oxford, England : 1990)|March 3, 2023
Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trialMarc Hilmi, Maud Kamal, Sophie Vacher, et al.
Gut|October 2, 2020
Microbiota tryptophan metabolism induces aryl hydrocarbon receptor activation and improves alcohol-induced liver injuryLaura Wrzosek, Dragos Ciocan, Cindy Hugot, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2008
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patientsHarry Sokol, Bénédicte Pigneur, Laurie Watterlot, et al.
Ebiomedicine|January 29, 2023
A high-throughput sequencing approach identifies immunotherapeutic targets for bacterial meningitis in neonatesStéphanie Pons, Eric Frapy, Youssouf Sereme, et al.
Annals of the Rheumatic Diseases|December 5, 2023
Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritisDavid Moulin, Marie Millard, Mahdia Taïeb, et al.
NPJ Biofilms and Microbiomes|June 12, 2025
Gut microbiota alterations are linked to COVID-19 severity in North African and European populationsMarius Bredon, Pierre Hausfater, Loubna Khalki, et al.
Gut Microbes|January 29, 2022
AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptomsMaëva Meynier, Elodie Baudu, Nathalie Rolhion, et al.
Journal of Crohn'S & Colitis|February 26, 2022
Impact of the Ileal Microbiota on Surgical Site Infections in Crohn's Disease: A Nationwide Prospective CohortClément Julien, Emré Anakok, Xavier Treton, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 1, 2023
Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexiaAdeline Dolly, Sarah A Pötgens, Morgane M Thibaut, et al.
Bulletin Du Cancer|February 15, 2020
[Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment]Romain Cohen, Thomas Pudlarz, Marie-Line Garcia-Larnicol, et al.
Pageof 27